CAS No.554-13-2,Lithium carbonate Suppliers

Products Categories

Pharmaceutical (177)
Others (125)
Organic Chemicals (60)
Basic Inorganic Chemicals (15)
Reagent (8)
Catalyst and Auxiliary (7)
Materials (6)
Agrochemicals (6)
Food Additives (3)
(1)
Dyestuff and Pigment (1)

Basic Information

Molecular Structure:
CAS No.:	554-13-2
Name:	Lithium carbonate
Article Data:	117

Formula:	Li₂CO₃
Molecular Weight:	73.8912
Synonyms:	Lithane;Lithium carbonate;Lithiumcarbonate;Plenur;Liticar;Litard;Limas;Eutimin;Lithea;Priadel;Li2CO3;Phasal;
EINECS:	209-062-5
Density:	2.11 g/cm³
Melting Point:	720 °C
Boiling Point:	333.6 °C at 760 mmHg
Flash Point:	169.8 °C
Solubility:	water: 13 g/L (20 °C)
Appearance:	white fine crystalline powder
Hazard Symbols:	Xn,C,F
Risk Codes:	36/38-41-36/37/38-22-36-34-20/21/22-15-14-11
Safety:	8-43-45-37/39-26-36/37-24/25-36/37/39-16-7/8-3/7/9
Transport Information:	UN 3264 8/PG 3
PSA:	63.19000
LogP:	-2.44700

Synthetic route

: 124-38-9
carbon dioxide

: 554-13-2
lithium carbonate

Conditions

Conditions	Yield
With C14H14B2(2-)*2Li(1+) In tetrahydrofuran at 25℃; under 760.051 Torr; Sealed tube; Cooling with liquid nitrogen; Inert atmosphere;	83%
With Tri-n-octylamine; water; lithium chloride In butan-1-ol under 7.50075E-06 Torr;
With lithium hydroxide monohydrate In water for 2.68333h; Kinetics; Time;
With C2H3OS2(1-)*Li(1+) In methanol

: 2Li(1+)*W(CO)5(2-)=Li2{W(CO)5}

: 124-38-9
carbon dioxide

A: 14040-11-0
tungsten hexacarbonyl

B: 554-13-2
lithium carbonate

Conditions

Conditions	Yield
In tetrahydrofuran reductive disproportionation; mechanism discussed;; IR;;	A 82% B 74%
In tetrahydrofuran soln. of the W-compound was treated with gasous CO2 at -78°C, warmed to 25°C; solvent removed (vac.), extd. (diethyl ether), ether removed (vac.); IR, MAS;	A 82% B 74%

...Expand

: 584-08-7
potassium carbonate

: lithium chloride

: 554-13-2
lithium carbonate

Conditions

Conditions	Yield
In not given pptn. from concd. LiCl soln. with excess of K2CO3;;
In not given pptn. from concd. LiCl soln. with excess of K2CO3;;

: lithium nitrate

: 584-08-7
potassium carbonate

: 554-13-2
lithium carbonate

Conditions

Conditions	Yield
In not given pptn. from concd. LiNO3 soln. with excess of K2CO3;;
In not given pptn. from concd. LiNO3 soln. with excess of K2CO3;;

: lithium sulfate

: 584-08-7
potassium carbonate

: 554-13-2
lithium carbonate

Conditions

Conditions	Yield
In not given
In not given pptn. from concd. Li2SO4 soln. with excess of K2CO3;;
In not given
In not given pptn. from concd. Li2SO4 soln. with excess of K2CO3;;

: 6108-17-4, 61013-21-6, 61013-23-8, 67299-15-4, 116277-84-0
lithium acetate dihydrate

: 554-13-2
lithium carbonate

Conditions

Conditions	Yield
With poly(methyl methacrylate); oxalic acid; Ni(CH3COO)2*4H2O In methanol byproducts: NiO; poly(methyl methacrylate) added; pptd. by adding of oxalic acid soln.; calcined at 298-400°C for 1-15 h in mixed atm. air/N2, at 400-600°C in air or O2; powder XRD;
In neat (no solvent, solid phase) heated for 1 h at 500°C; XRD;

: 6108-17-4, 61013-21-6, 61013-23-8, 67299-15-4, 116277-84-0
lithium acetate dihydrate

: 6018-89-9
nickel(II) acetate tetrahydrate

A: 1313-99-1
nickel(II) oxide

B: lithium nickelate(III)

C: 554-13-2
lithium carbonate

Conditions

Conditions	Yield
In water mixt. stirred, heated at 120 °C to remove water, heated at 250 °C for 24 h or at 370 °C for 24 h; detd. by XRD;

...Expand

: 1310-66-3
lithium hydroxide monohydrate

: 6018-89-9
nickel(II) acetate tetrahydrate

A: 1313-99-1
nickel(II) oxide

B: 554-13-2
lithium carbonate

Conditions

Conditions	Yield
In neat (no solvent) LiOH*H2O and Ni acetate separately dissolved in H2O; mixed; pH adjusted to 8.5-9.5; heated at 110°C until they were dry; calcined at 300-500°C; monitored by X-ray diffraction;

...Expand

: 1310-66-3
lithium hydroxide monohydrate

: 6018-89-9
nickel(II) acetate tetrahydrate

A: Li2Ni8O10

B: 554-13-2
lithium carbonate

Conditions

Conditions	Yield
In neat (no solvent) LiOH*H2O and Ni acetate separately dissolved in H2O; mixed; pH adjusted to 8.5-9.5; heated at 110°C until they were dry; calcined at 600°C; monitored by X-ray diffraction;

...Expand

: lithium peroxide

: 124-38-9
carbon dioxide

: 554-13-2
lithium carbonate

Conditions

Conditions	Yield
High Pressure; at 400°C, pressure of CO2: 2100 at for 6 h;

Raw Materials

6018-89-9

553-91-3

124-38-9

546-89-4

Downstream Products

556-63-8

Total:281 Page 1 of 8 1 2 3 4 5 6 …8 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 554-13-2

Specification

Lithium carbonate, its cas register number is 554-13-2. It also can be called Lithonate; Lithium hydroxide, solution; Eskalith; and Lithobid. Lithium carbonate, the most widely used of the compounds, is employed in the production of lithium metal and ft-its and enamels. Together with lithium fluoride (LiF), it serves as an additive for cryolite in the elec-trolytic pot line production of primary aluminum. It also is used to treat manic states and bipolar disorder, and is used in the manufacture of most LITHIUM-ion battery cathodes, which are made of lithlum cobalt oxide. It is manufactured from spodumene, which is by far the most important lithium-containing ore.

Physical properties about Lithium carbonate are: (1)ACD/LogP: -0.809; (2)ACD/LogD (pH 5.5): -1.98; (3)ACD/LogD (pH 7.4): -3.77; (4)ACD/BCF (pH 5.5): 1.00; (5)ACD/BCF (pH 7.4): 1.00; (6)ACD/KOC (pH 5.5): 1.00; (7)ACD/KOC (pH 7.4): 1.00; (8)#H bond acceptors: 3; (9)#H bond donors: 2; (10)Flash Point: 169.8 °C; (11)Enthalpy of Vaporization: 63.37 kJ/mol; (12)Boiling Point: 333.6 °C at 760 mmHg; (13)Vapour Pressure: 2.58E-05 mmHg at 25°C

You can still convert the following datas into molecular structure:
(1)InChI=1S/CH2O3.2Li/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2;
(2)InChIKey=XGZVUEUWXADBQD-UHFFFAOYSA-L;
(3)SmilesC(=O)([O-])[O-].[Li+].[Li+];

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
dog	LD50	oral	500mg/kg (500mg/kg)		"Psychotropic Drugs and Related Compounds," 2nd ed., Usdin, E., and D.H. Efron, Washington, DC, 1972Vol. -, Pg. 436, 1972.
human	TDLo	oral	4111mg/kg (4111mg/kg)	GASTROINTESTINAL: OTHER CHANGES BEHAVIORAL: TREMOR BEHAVIORAL: MUSCLE WEAKNESS	New England Journal of Medicine. Vol. 287, Pg. 867, 1972.
man	TDLo	oral	8mg/kg (8mg/kg)	GASTROINTESTINAL: NAUSEA OR VOMITING SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE"	American Journal of Psychiatry. Vol. 141, Pg. 909, 1984.
man	TDLo	oral	54mg/kg (54mg/kg)	BEHAVIORAL: SLEEP BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"	New Zealand Medical Journal. Vol. 97, Pg. 23, 1984.
man	TDLo	oral	1080mg/kg/13W (1080mg/kg)	SKIN AND APPENDAGES (SKIN): "DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE"	Journal of Clinical Psychiatry. Vol. 47, Pg. 330, 1986.
man	TDLo	oral	25gm/kg/4Y-I (25000mg/kg)	BEHAVIORAL: TREMOR SENSE ORGANS AND SPECIAL SENSES: MIOSIS (PUPILLARY CONSTRICTION): EYE	Journal of Clinical Psychiatry. Vol. 46, Pg. 292, 1985.
mouse	LD50	intraperitoneal	236mg/kg (236mg/kg)	BEHAVIORAL: ATAXIA BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) BEHAVIORAL: EXCITEMENT	Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973.
mouse	LD50	intravenous	497mg/kg (497mg/kg)	LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)	Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973.
mouse	LD50	oral	531mg/kg (531mg/kg)		Russian Pharmacology and Toxicology Vol. 33, Pg. 266, 1970.
mouse	LD50	subcutaneous	413mg/kg (413mg/kg)		Russian Pharmacology and Toxicology Vol. 33, Pg. 266, 1970.
rat	LD50	intraperitoneal	156mg/kg (156mg/kg)	GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA" LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973.
rat	LD50	intravenous	241mg/kg (241mg/kg)	BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX) LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION	Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973.
rat	LD50	oral	525mg/kg (525mg/kg)	LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"	Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973.
rat	LD50	subcutaneous	434mg/kg (434mg/kg)	SENSE ORGANS AND SPECIAL SENSES: LACRIMATION: EYE LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION SKIN AND APPENDAGES (SKIN): HAIR: OTHER	Kiso to Rinsho. Clinical Report. Vol. 7, Pg. 1273, 1973.
women	TDLo	oral	120mg/kg/10D- (120mg/kg)	BEHAVIORAL: EXCITEMENT	Journal of Clinical Psychiatry. Vol. 48, Pg. 81, 1987.
women	TDLo	oral	612mg/kg/44D- (612mg/kg)	SKIN AND APPENDAGES (SKIN): "DERMATITIS, ALLERGIC: AFTER SYSTEMIC EXPOSURE" BEHAVIORAL: SLEEP	American Journal of Psychiatry. Vol. 152, Pg. 956, 1995.
women	TDLo	oral	8760mg/kg/2Y- (8760mg/kg)	ENDOCRINE: EVIDENCE OF THYROID HYPERFUNCTION ENDOCRINE: THYROID WEIGHT (GOITER)	American Journal of Medicine. Vol. 99, Pg. 575, 1995.
women	TDLo	oral	36500mg/kg/10 (36500mg/kg)	ENDOCRINE: DIABETES INSIPIDUS (NEPHROGENIC OR CNS) KIDNEY, URETER, AND BLADDER: URINE VOLUME INCREASED KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)"	Annales de Medecine Interne. Vol. 148, Pg. 284, 1997.
women	TDLo	unreported	556mg/kg/32D (556mg/kg)	BEHAVIORAL: TOXIC PSYCHOSIS	JAMA, Journal of the American Medical Association. Vol. 213, Pg. 865, 1970.

Premium Related Products